Autolus Therapeutics Reports Second Quarter 2022 Financial Results and Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. QCOM
6. AZN
7. ORCL
8. AAPL
9. NVS
10. ROIV

Go back to Autolus Therapeutics Reports Second Quarter 2022 Financial Results and Operational Progress

Autolus Therapeutics (AUTL) Misses Q2 EPS by 4c

August 4, 2022 7:05 AM EDT

Autolus Therapeutics (NASDAQ: AUTL) reported Q2 EPS of ($0.46), $0.04 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

... More